<DrugInformationSummary id="CDR0000487488"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about imatinib mesylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/imatinibmesylate">Imatinib Mesylate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000037862">imatinib mesylate</TerminologyLink><GlossaryLink ref="CDR0000044893">imatinib mesylate</GlossaryLink><USBrandNames><USBrandName>Gleevec</USBrandName><USBrandName>Imkeldi</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>ih-MA-tih-nib MEH-zih-layt</TermPronunciation><MediaLink ref="CDR0000706105" type="audio/mpeg" alt="" language="en" id="_5"/><MediaLink ref="CDR0000706106" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Imatinib Mesylate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Imatinib mesylate is approved to treat:</Para><ItemizedList Style="bullet" id="_6"><ListItem><Strong><GlossaryTermRef href="CDR0000045586" dictionary="Cancer.gov" audience="Patient">Acute lymphoblastic leukemia</GlossaryTermRef></Strong> in adults and children that is <GlossaryTermRef href="CDR0000044179" dictionary="Cancer.gov" audience="Patient">Philadelphia chromosome</GlossaryTermRef> <GlossaryTermRef href="CDR0000044710" dictionary="Cancer.gov" audience="Patient">positive</GlossaryTermRef>. In adults, it is used for cancer that has come back or does not respond to treatment. In children, it is used with chemotherapy as the first treatment after the cancer is diagnosed.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000426408" dictionary="Cancer.gov" audience="Patient">Chronic eosinophilic leukemia</GlossaryTermRef></Strong> or <Strong>hypereosinophilic syndrome</Strong>  in adults.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000044901" dictionary="Cancer.gov" audience="Patient">Chronic myelogenous leukemia</GlossaryTermRef></Strong> that is Philadelphia chromosome positive. It is used in adults and children with:<ItemizedList Style="bullet" id="_7"><ListItem>newly-diagnosed <GlossaryTermRef href="CDR0000045160" dictionary="Cancer.gov" audience="Patient">chronic phase</GlossaryTermRef> cancer</ListItem><ListItem>chronic phase, <GlossaryTermRef href="CDR0000046212" dictionary="Cancer.gov" audience="Patient">accelerated phase</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000046113" dictionary="Cancer.gov" audience="Patient">blastic phase</GlossaryTermRef> cancer that got worse after <GlossaryTermRef href="CDR0000045324" dictionary="Cancer.gov" audience="Patient">interferon</GlossaryTermRef>-alpha therapy</ListItem></ItemizedList> </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000044276" dictionary="Cancer.gov" audience="Patient">Dermatofibrosarcoma protuberans</GlossaryTermRef></Strong> in adults whose cancer has come back,  has spread to other parts of the body, and/or cannot be removed by surgery.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000044998" dictionary="Cancer.gov" audience="Patient">Gastrointestinal stromal tumor</GlossaryTermRef></Strong> (GIST) that has the Kit protein and cannot be removed by surgery and/or has spread to other parts of the body. It is also used after surgery to completely remove the tumor  in  adults with <GeneName>KIT</GeneName>-positive cancer.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045266" dictionary="Cancer.gov" audience="Patient">Myelodysplastic</GlossaryTermRef>/<GlossaryTermRef href="CDR0000045210" dictionary="Cancer.gov" audience="Patient">myeloproliferative neoplasms</GlossaryTermRef></Strong> in adults whose cancer has an abnormal <GeneName>PDGFR</GeneName> gene.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000455141" dictionary="Cancer.gov" audience="Patient">Systemic mastocytosis</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000789073" dictionary="Cancer.gov" audience="Patient">aggressive</GlossaryTermRef> and either does not have the p.D816V c-Kit gene variant or the variant status is unknown.</ListItem></ItemizedList><Para id="_3">Imatinib mesylate is also being studied in the treatment of other conditions and types of cancer.</Para>                          
 </Section><Section id="_About"><Title>More About Imatinib Mesylate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/37862">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.27">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a606018.html">Imatinib Mesylate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.28"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.29">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2024/gist-uninterrupted-gleevec-treatment">Clinical Trial Results Support Uninterrupted Use of Imatinib for Some Gastrointestinal Stromal Tumors</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C1687">Find Clinical Trials for Imatinib Mesylate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2006-10-05</DateFirstPublished><DateLastModified>2025-01-09</DateLastModified></DrugInformationSummary>
